In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

The AI adverse event problem nobody is talking about reveals risks in FDA-cleared surgical devices lacking robust clinical trials.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

The field of neurodegenerative disease research is increasingly focused on the roles of the gut-brain axis and the gut microbiome in determining brain ...

A new research hub will create open-source computer models of organs to help accelerate the development of new medicines. The Modelling-Informed Medicine Centre (MiMeC), founded by the biopharma ...

One of the most widely accepted models for how cells remember their identity may be incorrect. This is shown in a new study ...

Researchers at OpenAI and Ginkgo Bioworks showed that an AI model working with an autonomous lab can design and iterate real ...

Researchers at the Center for Computational Sciences, University of Tsukuba, have developed an accessible platform to overcome the limitations of conventional static docking simulations, offering new ...

This technical FAQ examines three modeling gaps identified in engineering literature and outlines algorithmic methods to address them.

This is Colossus: a data center that Musk’s artificial-intelligence company, xAI, is using as a training ground for Grok, one ...

Artificial intelligence may be transforming pharmaceutical research, but it will not compress drug development timelines as dramatically as many expect, according to Bill Anderson, chief executive of ...